UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000049898
Receipt number R000056603
Scientific Title Donor stool analysis of stool transplantation therapy for patients with ulcerative colitis.
Date of disclosure of the study information 2022/12/26
Last modified on 2022/12/26 10:52:44

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Donor stool analysis of stool transplantation therapy for patients with ulcerative colitis.

Acronym

Donor stool analysis of stool transplantation therapy for patients with ulcerative colitis.

Scientific Title

Donor stool analysis of stool transplantation therapy for patients with ulcerative colitis.

Scientific Title:Acronym

Donor stool analysis of stool transplantation therapy for patients with ulcerative colitis.

Region

Japan


Condition

Condition

ulcerative colitis

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Analysis of the pathogenesis of ulcerative colitis (UC) to develop new treatment options

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

-

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

6 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Stool donors who participated in the preceding specific clinical study, "Single-center non-randomized study: Efficacy of fecal microbiota transplantation and antibiotics for inflammatory bowel disease and its factors.

Key exclusion criteria

Patients deemed unsuitable as subjects by the principal investigator

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Dai
Middle name
Last name Ishikawa

Organization

Juntendo University Hospital

Division name

Department of Gastroenterology

Zip code

113-8431

Address

3-1-3 Hongo,Bunkyo-ku,Tokyo

TEL

03-3813-3111

Email

dai@juntendo.ac.jp


Public contact

Name of contact person

1st name Dai
Middle name
Last name Ishikawa

Organization

Juntendo University Hospital

Division name

Department of Gastroenterology

Zip code

113-8431

Address

3-1-3 Hongo,Bunkyo-ku,Tokyo

TEL

03-3813-3111

Homepage URL


Email

dai@juntendo.ac.jp


Sponsor or person

Institute

Juntendo University

Institute

Department

Personal name



Funding Source

Organization

Metagen Therapeutics, Inc.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Research Ethics Committee Faculty of Medicine, Juntendo University

Address

3-1-3 Hongo,Bunkyo-ku,Tokyo

Tel

03-5802-1584

Email

hongo-rinri@juntendo.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 12 Month 26 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2022 Year 10 Month 28 Day

Date of IRB

2022 Year 10 Month 21 Day

Anticipated trial start date

2022 Year 10 Month 28 Day

Last follow-up date

2027 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

-


Management information

Registered date

2022 Year 12 Month 26 Day

Last modified on

2022 Year 12 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000056603


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name